{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:02Z","timestamp":1792090022042,"version":"4.4.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82522038"],"award-info":[{"award-number":["82522038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471670"],"award-info":[{"award-number":["82471670"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Project of China"},{"name":"National Science and Technology Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-026-01646-1","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:49:20Z","timestamp":1792086560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic homeostasis and women\u2019s reproductive health"],"prefix":"10.1038","author":[{"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-2613","authenticated-orcid":false,"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-6670","authenticated-orcid":false,"given":"Hsun-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-3825","authenticated-orcid":false,"given":"Liangshan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"1646_CR1","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","volume":"407","author":"HJ Teede","year":"2026","unstructured":"Teede, H. J. et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet 407, 2329\u20132339 (2026).","journal-title":"Lancet"},{"key":"1646_CR2","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s42255-026-01552-6","volume":"8","author":"P Kordowitzki","year":"2026","unstructured":"Kordowitzki, P. & Teede, H. Polyendocrine metabolic ovarian syndrome\u2014a new name for an old problem. Nat. Metab. 8, 1443\u20131445 (2026).","journal-title":"Nat. Metab."},{"key":"1646_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.fertnstert.2020.06.038","volume":"114","author":"ST Ruohonen","year":"2020","unstructured":"Ruohonen, S. T., Poutanen, M. & Tena-Sempere, M. Role of kisspeptins in the control of the hypothalamic\u2013pituitary\u2013ovarian axis: old dogmas and new challenges. Fertil. Steril. 114, 465\u2013474 (2020).","journal-title":"Fertil. Steril."},{"key":"1646_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen, M. G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 20, 12 (2018).","journal-title":"Curr. Hypertens. Rep."},{"key":"1646_CR5","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/liv.15866","volume":"44","author":"C Weng","year":"2024","unstructured":"Weng, C. et al. Association of sex hormones with non-alcoholic fatty liver disease: an observational and Mendelian randomization study. Liver Int. 44, 1154\u20131166 (2024).","journal-title":"Liver Int."},{"key":"1646_CR6","doi-asserted-by":"publisher","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","volume":"15","author":"B Kumarendran","year":"2018","unstructured":"Kumarendran, B. et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS Med. 15, e1002542 (2018).","journal-title":"PLoS Med."},{"key":"1646_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/obr.12762","volume":"20","author":"SS Lim","year":"2019","unstructured":"Lim, S. S. et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes. Rev. 20, 339\u2013352 (2019).","journal-title":"Obes. Rev."},{"key":"1646_CR8","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/humrep\/dex207","volume":"32","author":"LV Farland","year":"2017","unstructured":"Farland, L. V. et al. Associations among body size across the life course, adult height and endometriosis. Hum. Reprod. 32, 1732\u20131742 (2017).","journal-title":"Hum. Reprod."},{"key":"1646_CR9","doi-asserted-by":"publisher","first-page":"925206","DOI":"10.3389\/fendo.2022.925206","volume":"13","author":"Q Xie","year":"2022","unstructured":"Xie, Q. et al. The role of kisspeptin in the control of the hypothalamic\u2013pituitary\u2013gonadal axis and reproduction. Front. Endocrinol. 13, 925206 (2022).","journal-title":"Front. Endocrinol."},{"key":"1646_CR10","doi-asserted-by":"publisher","first-page":"889923","DOI":"10.3389\/fendo.2022.889923","volume":"13","author":"BM Steiner","year":"2022","unstructured":"Steiner, B. M. & Berry, D. C. The regulation of adipose tissue health by estrogens. Front. Endocrinol. 13, 889923 (2022).","journal-title":"Front. Endocrinol."},{"key":"1646_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113808","volume":"156","author":"F Mahboobifard","year":"2022","unstructured":"Mahboobifard, F. et al. Estrogen as a key regulator of energy homeostasis and metabolic health. Biomed. Pharmacother. 156, 113808 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1646_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db18-0638","volume":"68","author":"H Yan","year":"2019","unstructured":"Yan, H. et al. Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1. Diabetes 68, 291\u2013304 (2019).","journal-title":"Diabetes"},{"key":"1646_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47687-6","volume":"15","author":"W Yang","year":"2024","unstructured":"Yang, W. et al. An estrogen receptor \u03b1-derived peptide improves glucose homeostasis during obesity. Nat. Commun. 15, 3410 (2024).","journal-title":"Nat. Commun."},{"key":"1646_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1210\/jc.2014-1839","volume":"100","author":"R Karim","year":"2015","unstructured":"Karim, R. et al. Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. J. Clin. Endocrinol. Metab. 100, 508\u2013515 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR15","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1523\/JNEUROSCI.3138-16.2017","volume":"37","author":"OK Egan","year":"2017","unstructured":"Egan, O. K., Inglis, M. A. & Anderson, G. M. Leptin signaling in AgRP neurons modulates puberty onset and adult fertility in mice. J. Neurosci. 37, 3875\u20133886 (2017).","journal-title":"J. Neurosci."},{"key":"1646_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.metabol.2014.10.013","volume":"64","author":"MJ V\u00e1zquez","year":"2015","unstructured":"V\u00e1zquez, M. J., Romero-Ruiz, A. & Tena-Sempere, M. Roles of leptin in reproduction, pregnancy and polycystic ovary syndrome: consensus knowledge and recent developments. Metabolism 64, 79\u201391 (2015).","journal-title":"Metabolism"},{"key":"1646_CR17","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1073\/pnas.1621065114","volume":"114","author":"SL Padilla","year":"2017","unstructured":"Padilla, S. L. et al. AgRP to Kiss1 neuron signaling links nutritional state and fertility. Proc. Natl Acad. Sci. USA 114, 2413\u20132418 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1646_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF03346478","volume":"32","author":"M Karamouti","year":"2009","unstructured":"Karamouti, M. et al. Modulating effect of leptin on basal and follicle stimulating hormone stimulated steroidogenesis in cultured human lutein granulosa cells. J. Endocrinol. Invest. 32, 415\u2013419 (2009).","journal-title":"J. Endocrinol. Invest."},{"key":"1646_CR19","first-page":"1072","volume":"84","author":"SK Agarwal","year":"1999","unstructured":"Agarwal, S. K., Vogel, K., Weitsman, S. R. & Magoffin, D. A. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J. Clin. Endocrinol. Metab. 84, 1072\u20131076 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2007.08.076","volume":"90","author":"M Karamouti","year":"2008","unstructured":"Karamouti, M. et al. Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil. Steril. 90, 1444\u20131450 (2008).","journal-title":"Fertil. Steril."},{"key":"1646_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27093950","volume":"27","author":"SPW Fernando","year":"2026","unstructured":"Fernando, S. P. W. & Ramdass, P. V. A. K. Adiponectin and polycystic ovary syndrome in adolescent girls: a systematic review and meta-analysis. Int. J. Mol. Sci. 27, 3950 (2026).","journal-title":"Int. J. Mol. Sci."},{"key":"1646_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biom16060832","volume":"16","author":"Y Tian","year":"2026","unstructured":"Tian, Y. et al. Regulatory roles of adiponectin in animal reproduction: molecular insights from the hypothalamic\u2013pituitary\u2013gonadal axis. Biomolecules 16, 832 (2026).","journal-title":"Biomolecules"},{"key":"1646_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13005","volume":"21","author":"D Nieuwenhuis","year":"2020","unstructured":"Nieuwenhuis, D., Pujol-Gualdo, N., Arnoldussen, I. A. C. & Kiliaan, A. J. Adipokines: a gear shift in puberty. Obes. Rev. 21, e13005 (2020).","journal-title":"Obes. Rev."},{"key":"1646_CR24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00210-024-03441-9","volume":"398","author":"LF Laurindo","year":"2025","unstructured":"Laurindo, L. F. et al. Mechanisms and effects of AdipoRon, an adiponectin receptor agonist, on ovarian granulosa cells\u2014a systematic review. Naunyn Schmiedebergs Arch. Pharmacol. 398, 1305\u20131314 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"1646_CR25","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1210\/en.2015-2080","volume":"157","author":"L Cheng","year":"2016","unstructured":"Cheng, L. et al. Adiponectin deficiency leads to female subfertility and ovarian dysfunctions in mice. Endocrinology 157, 4875\u20134887 (2016).","journal-title":"Endocrinology"},{"key":"1646_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","volume":"116","author":"N Fuentes","year":"2019","unstructured":"Fuentes, N. & Silveyra, P. Estrogen receptor signaling mechanisms. Adv. Protein Chem. Struct. Biol. 116, 135\u2013170 (2019).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"1646_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/er.2018-00158","volume":"40","author":"M Grossmann","year":"2019","unstructured":"Grossmann, M., Wierman, M. E., Angus, P. & Handelsman, D. J. Reproductive endocrinology of nonalcoholic fatty liver disease. Endocr. Rev. 40, 417\u2013446 (2019).","journal-title":"Endocr. Rev."},{"key":"1646_CR28","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-16-0070","volume":"230","author":"GL Hammond","year":"2016","unstructured":"Hammond, G. L. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J. Endocrinol. 230, R13\u2013R25 (2016).","journal-title":"J. Endocrinol."},{"key":"1646_CR29","doi-asserted-by":"publisher","first-page":"E2780","DOI":"10.1210\/jc.2014-2640","volume":"99","author":"SJ Winters","year":"2014","unstructured":"Winters, S. J. et al. Sex hormone-binding globulin gene expression and insulin resistance. J. Clin. Endocrinol. Metab. 99, E2780\u2013E2788 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1210\/jc.2018-00740","volume":"104","author":"C S\u00e1ez-L\u00f3pez","year":"2019","unstructured":"S\u00e1ez-L\u00f3pez, C. et al. Sex hormone-binding globulin expression correlates with acetyl-coenzyme A carboxylase and triglyceride content in human liver. J. Clin. Endocrinol. Metab. 104, 1500\u20131507 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR31","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1210\/en.2014-1072","volume":"155","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3, R. et al. Adiponectin upregulates SHBG production: molecular mechanisms and potential implications. Endocrinology 155, 2820\u20132830 (2014).","journal-title":"Endocrinology"},{"key":"1646_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2009.09.020","volume":"316","author":"M Pugeat","year":"2010","unstructured":"Pugeat, M. et al. Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol. Cell. Endocrinol. 316, 53\u201359 (2010).","journal-title":"Mol. Cell. Endocrinol."},{"key":"1646_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","volume":"16","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich, V., Sanguankeo, A., Riangwiwat, T. & Upala, S. Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann. Hepatol. 16, 382\u2013394 (2017).","journal-title":"Ann. Hepatol."},{"key":"1646_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","volume":"64","author":"R Deswal","year":"2018","unstructured":"Deswal, R., Yadav, A. & Dang, A. S. Sex hormone binding globulin\u2014an important biomarker for predicting PCOS risk: a systematic review and meta-analysis. Syst. Biol. Reprod. Med. 64, 12\u201324 (2018).","journal-title":"Syst. Biol. Reprod. Med."},{"key":"1646_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108480","volume":"85","author":"C Saez-Lopez","year":"2020","unstructured":"Saez-Lopez, C., Villena, J. A., Sim\u00f3, R. & Selva, D. M. Sex hormone-binding globulin overexpression protects against high-fat diet-induced obesity in transgenic male mice. J. Nutr. Biochem. 85, 108480 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"1646_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"35","author":"N Stefan","year":"2023","unstructured":"Stefan, N., Schick, F., Birkenfeld, A. L., H\u00e4ring, H.-U. & White, M. F. The role of hepatokines in NAFLD. Cell Metab. 35, 236\u2013252 (2023).","journal-title":"Cell Metab."},{"key":"1646_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.195","volume":"10","author":"L Hua","year":"2020","unstructured":"Hua, L. et al. Time-restricted feeding improves the reproductive function of female mice via liver fibroblast growth factor 21. Clin. Transl. Med. 10, e195 (2020).","journal-title":"Clin. Transl. Med."},{"key":"1646_CR38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/nm.3250","volume":"19","author":"BM Owen","year":"2013","unstructured":"Owen, B. M. et al. FGF21 contributes to neuroendocrine control of female reproduction. Nat. Med. 19, 1153\u20131156 (2013).","journal-title":"Nat. Med."},{"key":"1646_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.theriogenology.2022.09.020","volume":"194","author":"Y Hu","year":"2022","unstructured":"Hu, Y. et al. Fibroblast growth factor 21 (FGF21) promotes porcine granulosa cell estradiol production and proliferation via PI3K\/AKT\/mTOR signaling. Theriogenology 194, 1\u201312 (2022).","journal-title":"Theriogenology"},{"key":"1646_CR40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2337\/diab.33.4.324","volume":"33","author":"S Katayama","year":"1984","unstructured":"Katayama, S., Brownscheidle, C. M., Wootten, V., Lee, J. B. & Shimaoka, K. Absent or delayed preovulatory luteinizing hormone surge in experimental diabetes mellitus. Diabetes 33, 324\u2013327 (1984).","journal-title":"Diabetes"},{"key":"1646_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(19)30345-6","volume":"8","author":"EP Thong","year":"2020","unstructured":"Thong, E. P., Codner, E., Laven, J. S. E. & Teede, H. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 8, 134\u2013149 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1646_CR42","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/REP-06-0244","volume":"133","author":"C Chabrolle","year":"2007","unstructured":"Chabrolle, C., Tosca, L. & Dupont, J. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction 133, 719\u2013731 (2007).","journal-title":"Reproduction"},{"key":"1646_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42801-6","volume":"14","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y. et al. Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets. Nat. Commun. 14, 6991 (2023).","journal-title":"Nat. Commun."},{"key":"1646_CR44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43999","volume":"8","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Genetic dissection of the different roles of hypothalamic kisspeptin neurons in regulating female reproduction. eLife 8, e43999 (2019).","journal-title":"eLife"},{"key":"1646_CR45","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/physrev.00037.2010","volume":"92","author":"L Pinilla","year":"2012","unstructured":"Pinilla, L., Aguilar, E., Dieguez, C., Millar, R. P. & Tena-Sempere, M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol. Rev. 92, 1235\u20131316 (2012).","journal-title":"Physiol. Rev."},{"key":"1646_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1530\/JOE-12-0054","volume":"214","author":"J-P Wen","year":"2012","unstructured":"Wen, J.-P. et al. Adiponectin inhibits KISS1 gene transcription through AMPK and specificity protein-1 in the hypothalamic GT1-7 neurons. J. Endocrinol. 214, 177\u2013189 (2012).","journal-title":"J. Endocrinol."},{"key":"1646_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.70008","volume":"27","author":"S Zhang","year":"2026","unstructured":"Zhang, S. et al. Exploring the role of kisspeptin in polycystic ovary syndrome and its associated pregnancy complications. Obes. Rev. 27, 1\u201321 (2026).","journal-title":"Obes. Rev."},{"key":"1646_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/acel.12331","volume":"14","author":"X-M Liu","year":"2015","unstructured":"Liu, X.-M. et al. FSH regulates fat accumulation and redistribution in aging through the G\u03b1i\/Ca2+\/CREB pathway. Aging Cell 14, 409\u2013420 (2015).","journal-title":"Aging Cell"},{"key":"1646_CR49","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s00125-018-4562-x","volume":"61","author":"X Qi","year":"2018","unstructured":"Qi, X. et al. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice. Diabetologia 61, 1180\u20131192 (2018).","journal-title":"Diabetologia"},{"key":"1646_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41422-018-0123-6","volume":"29","author":"Y Guo","year":"2019","unstructured":"Guo, Y. et al. Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol. Cell Res. 29, 151\u2013166 (2019).","journal-title":"Cell Res."},{"key":"1646_CR51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/jc.2015-2724","volume":"101","author":"Y Song","year":"2016","unstructured":"Song, Y. et al. Follicle-stimulating hormone induces postmenopausal dyslipidemia through inhibiting hepatic cholesterol metabolism. J. Clin. Endocrinol. Metab. 101, 254\u2013263 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/biom12121736","volume":"12","author":"D Khan","year":"2022","unstructured":"Khan, D. et al. Evidence for involvement of GIP and GLP-1 receptors and the gut\u2013gonadal axis in regulating female reproductive function in mice. Biomolecules 12, 1736 (2022).","journal-title":"Biomolecules"},{"key":"1646_CR53","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/humupd\/dmz019","volume":"25","author":"M Jensterle","year":"2019","unstructured":"Jensterle, M. et al. The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective. Hum. Reprod. Update 25, 504\u2013517 (2019).","journal-title":"Hum. Reprod. Update"},{"key":"1646_CR54","doi-asserted-by":"publisher","first-page":"E1967","DOI":"10.1210\/jc.2013-2815","volume":"98","author":"M Brower","year":"2013","unstructured":"Brower, M., Brennan, K., Pall, M. & Azziz, R. The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. J. Clin. Endocrinol. Metab. 98, E1967\u2013E1971 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/humupd\/dmaf030","volume":"32","author":"ACH Neven","year":"2026","unstructured":"Neven, A. C. H. et al. Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis. Hum. Reprod. Update 32, 277\u2013312 (2026).","journal-title":"Hum. Reprod. Update"},{"key":"1646_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-026-06761-y","author":"E Stener-Victorin","year":"2026","unstructured":"Stener-Victorin, E., Carlsson, S., Hagstr\u00f6m, H. & Taebnia, N. MASLD, diabetes and PMOS across the female life stages. Diabetologia https:\/\/doi.org\/10.1007\/s00125-026-06761-y (2026).","journal-title":"Diabetologia"},{"key":"1646_CR57","doi-asserted-by":"publisher","first-page":"1480528","DOI":"10.3389\/fendo.2025.1480528","volume":"16","author":"S-H Hong","year":"2025","unstructured":"Hong, S.-H. et al. The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease. Front. Endocrinol. 16, 1480528 (2025).","journal-title":"Front. Endocrinol."},{"key":"1646_CR58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2024.0419","volume":"31","author":"C Meda","year":"2025","unstructured":"Meda, C., Dolce, A. & Torre, S. D. Metabolic dysfunction-associated steatotic liver disease across women\u2019s reproductive lifespan and issues. Clin. Mol. Hepatol. 31, 327\u2013332 (2025).","journal-title":"Clin. Mol. Hepatol."},{"key":"1646_CR59","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ajg.2017.44","volume":"112","author":"M Sarkar","year":"2017","unstructured":"Sarkar, M. et al. Testosterone levels in pre-menopausal women are associated with nonalcoholic fatty liver disease in midlife. Am. J. Gastroenterol. 112, 755\u2013762 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"1646_CR60","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1042\/BCJ20160124","volume":"473","author":"J Dupont","year":"2016","unstructured":"Dupont, J. & Scaramuzzi, R. J. Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle. Biochem. J. 473, 1483\u20131501 (2016).","journal-title":"Biochem. J."},{"key":"1646_CR61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7861\/clinmedicine.16-3-262","volume":"16","author":"TM Barber","year":"2016","unstructured":"Barber, T. M., Dimitriadis, G. K., Andreou, A. & Franks, S. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin. Med. 16, 262\u2013266 (2016).","journal-title":"Clin. Med."},{"key":"1646_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2008-0030","volume":"30","author":"S Palomba","year":"2009","unstructured":"Palomba, S., Falbo, A., Zullo, F. & Orio, F. Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr. Rev. 30, 1\u201350 (2009).","journal-title":"Endocr. Rev."},{"key":"1646_CR63","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/humrep\/des137","volume":"27","author":"X-H Ou","year":"2012","unstructured":"Ou, X.-H. et al. Maternal insulin resistance causes oxidative stress and mitochondrial dysfunction in mouse oocytes. Hum. Reprod. 27, 2130\u20132145 (2012).","journal-title":"Hum. Reprod."},{"key":"1646_CR64","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1210\/me.2012-1152","volume":"26","author":"R Sim\u00f3","year":"2012","unstructured":"Sim\u00f3, R., Barbosa-Desongles, A., Hernandez, C. & Selva, D. M. IL1\u03b2 down-regulation of sex hormone-binding globulin production by decreasing HNF-4\u03b1 via MEK-1\/2 and JNK MAPK pathways. Mol. Endocrinol. 26, 1917\u20131927 (2012).","journal-title":"Mol. Endocrinol."},{"key":"1646_CR65","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1210\/me.2011-1321","volume":"26","author":"R Sim\u00f3","year":"2012","unstructured":"Sim\u00f3, R. et al. Molecular mechanism of TNF\u03b1-induced down-regulation of SHBG expression. Mol. Endocrinol. 26, 438\u2013446 (2012).","journal-title":"Mol. Endocrinol."},{"key":"1646_CR66","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09513590903247873","volume":"26","author":"D Glintborg","year":"2010","unstructured":"Glintborg, D. & Andersen, M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol. Endocrinol. 26, 281\u2013296 (2010).","journal-title":"Gynecol. Endocrinol."},{"key":"1646_CR67","doi-asserted-by":"publisher","first-page":"e3330","DOI":"10.1210\/clinem\/dgac261","volume":"107","author":"G Ostinelli","year":"2022","unstructured":"Ostinelli, G. et al. Increased adipose tissue indices of androgen catabolism and aromatization in women with metabolic dysfunction. J. Clin. Endocrinol. Metab. 107, e3330\u2013e3342 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR68","doi-asserted-by":"publisher","first-page":"845165","DOI":"10.3389\/fendo.2022.845165","volume":"13","author":"Y Peng","year":"2022","unstructured":"Peng, Y. et al. Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome. Front. Endocrinol. 13, 845165 (2022).","journal-title":"Front. Endocrinol."},{"key":"1646_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218191","volume":"21","author":"X Qu","year":"2020","unstructured":"Qu, X. & Donnelly, R. Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int. J. Mol. Sci. 21, 8191 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1646_CR70","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12020-023-03590-6","volume":"84","author":"D Wang","year":"2024","unstructured":"Wang, D. et al. Androgens exacerbate hepatic triglyceride accumulation in rats with polycystic ovary syndrome by downregulating MTTP expression. Endocrine 84, 735\u2013744 (2024).","journal-title":"Endocrine"},{"key":"1646_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/JOE-21-0040","volume":"250","author":"T Seidu","year":"2021","unstructured":"Seidu, T. et al. DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice. J. Endocrinol. 250, 49\u201365 (2021).","journal-title":"J. Endocrinol."},{"key":"1646_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/HYPERTENSIONAHA.117.09056","volume":"70","author":"F Mu","year":"2017","unstructured":"Mu, F. et al. Association between endometriosis and hypercholesterolemia or hypertension. Hypertension 70, 59\u201365 (2017).","journal-title":"Hypertension"},{"key":"1646_CR73","doi-asserted-by":"publisher","first-page":"466","DOI":"10.7150\/ijbs.117146","volume":"22","author":"P Yang","year":"2026","unstructured":"Yang, P. et al. SLC25A1-mediated cholesterol accumulation promotes endometriosis progression by enhancing endometrial stromal cell proliferation, invasion, and M2 macrophage polarization. Int. J. Biol. Sci. 22, 466\u2013480 (2026).","journal-title":"Int. J. Biol. Sci."},{"key":"1646_CR74","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/humrep\/deaf040","volume":"40","author":"N Lin","year":"2025","unstructured":"Lin, N. et al. Plasma metabolites associated with endometriosis in adolescents and young adults. Hum. Reprod. 40, 843\u2013854 (2025).","journal-title":"Hum. Reprod."},{"key":"1646_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(24)00825-0","volume":"404","author":"A Sweeting","year":"2024","unstructured":"Sweeting, A. et al. Epidemiology and management of gestational diabetes. Lancet 404, 175\u2013192 (2024).","journal-title":"Lancet"},{"key":"1646_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-019-0362-0","volume":"77","author":"AA Muche","year":"2019","unstructured":"Muche, A. A., Olayemi, O. O. & Gete, Y. K. Prevalence and determinants of gestational diabetes mellitus in Africa based on the updated international diagnostic criteria: a systematic review and meta-analysis. Arch. Public Health 77, 36 (2019).","journal-title":"Arch. Public Health"},{"key":"1646_CR77","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1210\/clinem\/dgab571","volume":"106","author":"F Alvarado-Flores","year":"2021","unstructured":"Alvarado-Flores, F. et al. Placental miR-3940-3p is associated with maternal insulin resistance in late pregnancy. J. Clin. Endocrinol. Metab. 106, 3526\u20133535 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR78","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41574-022-00734-y","volume":"18","author":"L Jiang","year":"2022","unstructured":"Jiang, L. et al. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat. Rev. Endocrinol. 18, 760\u2013775 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1646_CR79","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00109-021-02068-0","volume":"99","author":"G van Niekerk","year":"2021","unstructured":"van Niekerk, G., Christowitz, C. & Engelbrecht, A.-M. Insulin-mediated immune dysfunction in the development of preeclampsia. J. Mol. Med. 99, 889\u2013897 (2021).","journal-title":"J. Mol. Med."},{"key":"1646_CR80","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tem.2015.02.002","volume":"26","author":"C Zheng","year":"2015","unstructured":"Zheng, C. & Liu, Z. Vascular function, insulin action, and exercise: an intricate interplay. Trends Endocrinol. Metab. 26, 297\u2013304 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"1646_CR81","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/humrep\/deq025","volume":"25","author":"IV Landres","year":"2010","unstructured":"Landres, I. V., Milki, A. A. & Lathi, R. B. Karyotype of miscarriages in relation to maternal weight. Hum. Reprod. 25, 1123\u20131126 (2010).","journal-title":"Hum. Reprod."},{"key":"1646_CR82","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/humrep\/deaf100","volume":"40","author":"AB Albert","year":"2025","unstructured":"Albert, A. B. et al. Association of insulin resistance with in vitro fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment. Hum. Reprod. 40, 1562\u20131569 (2025).","journal-title":"Hum. Reprod."},{"key":"1646_CR83","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1001\/jama.2013.6295","volume":"309","author":"S Cnattingius","year":"2013","unstructured":"Cnattingius, S. et al. Maternal obesity and risk of preterm delivery. JAMA 309, 2362\u20132370 (2013).","journal-title":"JAMA"},{"key":"1646_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110224","volume":"195","author":"Q You","year":"2023","unstructured":"You, Q. et al. Miscarriage, stillbirth and the risk of diabetes in women: a systematic review and meta-analysis. Diabetes Res. Clin. Pract. 195, 110224 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1646_CR85","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/1471-0528.17368","volume":"130","author":"LE Janssen","year":"2023","unstructured":"Janssen, L. E., de Boer, M. A., von K\u00f6nigsl\u00f6w, E. C. E., Oudijk, M. A. & de Groot, C. J. M. The association between spontaneous preterm birth and maternal hypertension in the fifth decade of life: a retrospective case\u2013control study. BJOG 130, 507\u2013513 (2023).","journal-title":"BJOG"},{"key":"1646_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-05256-z","volume":"22","author":"W-Y Cai","year":"2022","unstructured":"Cai, W.-Y., Luo, X., Lv, H.-Y., Fu, K.-Y. & Xu, J. Insulin resistance in women with recurrent miscarriage: a systematic review and meta-analysis. BMC Pregnancy Childbirth 22, 916 (2022).","journal-title":"BMC Pregnancy Childbirth"},{"key":"1646_CR87","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/hep.32540","volume":"76","author":"C Amadou","year":"2022","unstructured":"Amadou, C. et al. Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort. Hepatology 76, 1438\u20131451 (2022).","journal-title":"Hepatology"},{"key":"1646_CR88","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-023-00926-7","volume":"21","author":"JM Mehta","year":"2024","unstructured":"Mehta, J. M. & Manson, J. E. The menopausal transition period and cardiovascular risk. Nat. Rev. Cardiol. 21, 203\u2013211 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"1646_CR89","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1210\/jc.2010-1746","volume":"96","author":"JF Randolph Jr.","year":"2011","unstructured":"Randolph, J. F. Jr. et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J. Clin. Endocrinol. Metab. 96, 746\u2013754 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR90","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/humrep\/dez015","volume":"34","author":"InterLACE Study Team.","year":"2019","unstructured":"InterLACE Study Team. Variations in reproductive events across life: a pooled analysis of data from 505 147 women across 10 countries. Hum. Reprod. 34, 881\u2013893 (2019).","journal-title":"Hum. Reprod."},{"key":"1646_CR91","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41574-022-00708-0","volume":"18","author":"I Lambrinoudaki","year":"2022","unstructured":"Lambrinoudaki, I., Paschou, S. A., Armeni, E. & Goulis, D. G. The interplay between diabetes mellitus and menopause: clinical implications. Nat. Rev. Endocrinol. 18, 608\u2013622 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1646_CR92","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1210\/jc.2011-1923","volume":"97","author":"S Isik","year":"2012","unstructured":"Isik, S. et al. Evaluation of ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 97, 261\u2013269 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR93","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede, H. J. et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertil. Steril. 120, 767\u2013793 (2023).","journal-title":"Fertil. Steril."},{"key":"1646_CR94","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/s41591-026-04316-7","volume":"32","author":"S Corapi","year":"2026","unstructured":"Corapi, S. et al. Time-restricted eating for body weight management in women with polycystic ovary syndrome: a randomized controlled trial. Nat. Med. 32, 2155\u20132163 (2026).","journal-title":"Nat. Med."},{"key":"1646_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01411-1","volume":"23","author":"R Cannarella","year":"2025","unstructured":"Cannarella, R. et al. Effects of ketogenic diets on polycystic ovary syndrome: a systematic review and meta-analysis. Reprod. Biol. Endocrinol. 23, 74 (2025).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1646_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-20621-6","volume":"15","author":"M Noormohammadi","year":"2025","unstructured":"Noormohammadi, M. et al. Mediterranean diet adherence and healthy diet indicator might decrease odds of endometriosis. Sci. Rep. 15, 36750 (2025).","journal-title":"Sci. Rep."},{"key":"1646_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/nu18010142","volume":"18","author":"D Boroncsok","year":"2026","unstructured":"Boroncsok, D. et al. The role of lifestyle and diet in the treatment of endometriosis: a review. Nutrients 18, 142 (2026).","journal-title":"Nutrients"},{"key":"1646_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-026-01563-8","volume":"24","author":"S Hu","year":"2026","unstructured":"Hu, S. et al. Ranking exercise interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis. Reprod. Biol. Endocrinol. 24, 62 (2026).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1646_CR99","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.21507","volume":"14","author":"X Chen","year":"2026","unstructured":"Chen, X., Liu, Y., Chen, D. & Chen, L. Effects of exercise on reproductive endocrine hormones in adult patients with polycystic ovary syndrome: a systematic review and three-level meta-analysis. PeerJ 14, e21507 (2026).","journal-title":"PeerJ"},{"key":"1646_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-026-02836-0","author":"M Molinaro","year":"2026","unstructured":"Molinaro, M. et al. Effects of physical exercise on menstrual symptoms in polycystic ovary syndrome: a systematic review. J. Endocrinol. Invest. https:\/\/doi.org\/10.1007\/s40618-026-02836-0 (2026).","journal-title":"J. Endocrinol. Invest."},{"key":"1646_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317820","volume":"20","author":"M Xie","year":"2025","unstructured":"Xie, M. et al. The effectiveness and safety of physical activity and exercise on women with endometriosis: a systematic review and meta-analysis. PLoS ONE 20, e0317820 (2025).","journal-title":"PLoS ONE"},{"key":"1646_CR102","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/bjsports-2026-111586","volume":"60","author":"L Li","year":"2026","unstructured":"Li, L. et al. Effects of supervised exercise during pregnancy on gestational diabetes mellitus and other pregnancy outcomes: a systematic review and meta-analysis. Br. J. Sports Med. 60, 1350\u20131358 (2026).","journal-title":"Br. J. Sports Med."},{"key":"1646_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13737","volume":"25","author":"JL Benham","year":"2024","unstructured":"Benham, J. L. et al. Impact of bariatric surgery on anthropometric, metabolic, and reproductive outcomes in polycystic ovary syndrome: a systematic review and meta-analysis. Obes. Rev. 25, e13737 (2024).","journal-title":"Obes. Rev."},{"key":"1646_CR104","doi-asserted-by":"publisher","first-page":"1682379","DOI":"10.3389\/fendo.2025.1682379","volume":"16","author":"H Mirghani","year":"2026","unstructured":"Mirghani, H. & Shaman, A. Bariatric surgery as a treatment of polycystic ovary syndrome: a systematic review and meta-analysis. Front. Endocrinol. 16, 1682379 (2026).","journal-title":"Front. Endocrinol."},{"key":"1646_CR105","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(24)00538-5","volume":"403","author":"SNS Samarasinghe","year":"2024","unstructured":"Samarasinghe, S. N. S. et al. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial. Lancet 403, 2489\u20132503 (2024).","journal-title":"Lancet"},{"key":"1646_CR106","doi-asserted-by":"publisher","first-page":"e3217","DOI":"10.1210\/clinem\/dgac294","volume":"107","author":"L Hu","year":"2022","unstructured":"Hu, L. et al. Efficacy of bariatric surgery in the treatment of women with obesity and polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 107, e3217\u2013e3229 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","volume":"137","author":"D Kirpichnikov","year":"2002","unstructured":"Kirpichnikov, D., McFarlane, S. I. & Sowers, J. R. Metformin: an update. Ann. Intern. Med. 137, 25\u201333 (2002).","journal-title":"Ann. Intern. Med."},{"key":"1646_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00772-7","volume":"19","author":"L Yuan","year":"2021","unstructured":"Yuan, L. et al. The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis. Reprod. Biol. Endocrinol. 19, 89 (2021).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1646_CR109","doi-asserted-by":"publisher","first-page":"e817","DOI":"10.1210\/clinem\/dgad465","volume":"109","author":"J Melin","year":"2024","unstructured":"Melin, J. et al. Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 109, e817\u2013e836 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR110","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/ejendo\/lvad098","volume":"189","author":"J Melin","year":"2023","unstructured":"Melin, J. et al. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Endocrinol. 189, S37\u2013S63 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"1646_CR111","volume":"12","author":"A Sharpe","year":"2019","unstructured":"Sharpe, A., Morley, L. C., Tang, T., Norman, R. J. & Balen, A. H. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst. Rev. 12, CD013505 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1646_CR112","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajog.2025.05.038","volume":"233","author":"J Cheshire","year":"2025","unstructured":"Cheshire, J. et al. Preconception and first-trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 233, 530\u2013547 (2025).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1646_CR113","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS L\u00f8vvik","year":"2019","unstructured":"L\u00f8vvik, T. S. et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 7, 256\u2013266 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1646_CR114","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1210\/jc.2018-00485","volume":"103","author":"MO Underdal","year":"2018","unstructured":"Underdal, M. O. et al. Does metformin treatment during pregnancy modify the future metabolic profile in women with PCOS? J. Clin. Endocrinol. Metab. 103, 2408\u20132413 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR115","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/jc.2017-02419","volume":"103","author":"LGE Hanem","year":"2018","unstructured":"Hanem, L. G. E. et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J. Clin. Endocrinol. Metab. 103, 1612\u20131621 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins, J. L., Aiken, C. E. & Ozanne, S. E. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 16, e1002848 (2019).","journal-title":"PLoS Med."},{"key":"1646_CR117","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2023.19869","volume":"330","author":"F Dunne","year":"2023","unstructured":"Dunne, F. et al. Early metformin in gestational diabetes: a randomized clinical trial. JAMA 330, 1547\u20131556 (2023).","journal-title":"JAMA"},{"key":"1646_CR118","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2103","volume":"374","author":"CA Cluver","year":"2021","unstructured":"Cluver, C. A. et al. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ 374, n2103 (2021).","journal-title":"BMJ"},{"key":"1646_CR119","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq1475","volume":"8","author":"DA Landry","year":"2022","unstructured":"Landry, D. A. et al. Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice. Sci. Adv. 8, eabq1475 (2022).","journal-title":"Sci. Adv."},{"key":"1646_CR120","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.18632\/aging.102016","volume":"11","author":"X Qin","year":"2019","unstructured":"Qin, X. et al. Metformin prevents murine ovarian aging. Aging 11, 3785\u20133794 (2019).","journal-title":"Aging"},{"key":"1646_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030556","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Effects of a dulaglutide plus calorie-restricted diet versus a calorie-restricted diet on visceral fat and metabolic profiles in women with polycystic ovary syndrome: a randomized controlled trial. Nutrients 15, 556 (2023).","journal-title":"Nutrients"},{"key":"1646_CR122","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","volume":"14","author":"A Andersen","year":"2018","unstructured":"Andersen, A., Lund, A., Knop, F. K. & Vilsb\u00f8ll, T. Glucagon-like peptide 1 in health and disease. Nat. Rev. Endocrinol. 14, 390\u2013403 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1646_CR123","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1484321","volume":"2020","author":"Z Sun","year":"2020","unstructured":"Sun, Z. et al. GLP-1\/GLP-1R signaling regulates ovarian PCOS-associated granulosa cells proliferation and antiapoptosis by modification of forkhead box protein O1 phosphorylation sites. Int. J. Endocrinol. 2020, 1484321 (2020).","journal-title":"Int. J. Endocrinol."},{"key":"1646_CR124","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/biolre\/ioad032","volume":"108","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue. Biol. Reprod. 108, 945\u2013959 (2023).","journal-title":"Biol. Reprod."},{"key":"1646_CR125","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s43032-023-01222-y","volume":"30","author":"Z-R Ye","year":"2023","unstructured":"Ye, Z.-R., Yan, C.-Q., Liao, N. & Wen, S.-H. The effectiveness and safety of exenatide versus metformin in patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Reprod. Sci. 30, 2349\u20132361 (2023).","journal-title":"Reprod. Sci."},{"key":"1646_CR126","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1111\/dom.70452","volume":"28","author":"Y-T Lu","year":"2026","unstructured":"Lu, Y.-T. et al. Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis. Diabetes Obes. Metab. 28, 2523\u20132535 (2026).","journal-title":"Diabetes Obes. Metab."},{"key":"1646_CR127","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","volume":"118","author":"KE Elkind-Hirsch","year":"2022","unstructured":"Elkind-Hirsch, K. E., Chappell, N., Shaler, D., Storment, J. & Bellanger, D. Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertil. Steril. 118, 371\u2013381 (2022).","journal-title":"Fertil. Steril."},{"key":"1646_CR128","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","volume":"35","author":"M Nylander","year":"2017","unstructured":"Nylander, M. et al. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod. Biomed. Online 35, 121\u2013127 (2017).","journal-title":"Reprod. Biomed. Online"},{"key":"1646_CR129","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00404-022-06700-3","volume":"306","author":"R Li","year":"2022","unstructured":"Li, R., Mai, T., Zheng, S. & Zhang, Y. Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT. Arch. Gynecol. Obstet. 306, 1711\u20131721 (2022).","journal-title":"Arch. Gynecol. Obstet."},{"key":"1646_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-18-0175","volume":"179","author":"V Salamun","year":"2018","unstructured":"Salamun, V., Jensterle, M., Janez, A. & Vrtacnik Bokal, E. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur. J. Endocrinol. 179, 1\u201311 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"1646_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01447-3","volume":"23","author":"H Chen","year":"2025","unstructured":"Chen, H. et al. Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight\/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial. Reprod. Biol. Endocrinol. 23, 108 (2025).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1646_CR132","volume":"233","author":"MR Imbroane","year":"2025","unstructured":"Imbroane, M. R., LeMoine, F. & Nau, C. T. Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes. Am. J. Obstet. Gynecol. 233, 116 (2025).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1646_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.103023","volume":"7","author":"F Tavaglione","year":"2026","unstructured":"Tavaglione, F. & Loomba, R. Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis. Cell Rep. Med. 7, 103023 (2026).","journal-title":"Cell Rep. Med."},{"key":"1646_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52898-y","volume":"15","author":"MA S\u00e1nchez-Garrido","year":"2024","unstructured":"S\u00e1nchez-Garrido, M. A. et al. Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy. Nat. Commun. 15, 8498 (2024).","journal-title":"Nat. Commun."},{"key":"1646_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118837","volume":"193","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z., Li, Y., Gu, H. F. & Li, N. Pharmacological mechanisms and clinical applications between SGLT1 and SGLT2 inhibitors in type 2 diabetes and diabetic kidney disease: an analytic review. Biomed. Pharmacother. 193, 118837 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"1646_CR136","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/dom.14583","volume":"24","author":"M Cai","year":"2022","unstructured":"Cai, M. et al. Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: a randomized, open-label, noninferiority trial. Diabetes Obes. Metab. 24, 312\u2013320 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"1646_CR137","doi-asserted-by":"publisher","first-page":"1003238","DOI":"10.3389\/fendo.2022.1003238","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Xing, C., Cheng, X. & He, B. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial. Front. Endocrinol. 13, 1003238 (2022).","journal-title":"Front. Endocrinol."},{"key":"1646_CR138","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1210\/clinem\/dgab408","volume":"106","author":"KE Elkind-Hirsch","year":"2021","unstructured":"Elkind-Hirsch, K. E., Chappell, N., Seidemann, E., Storment, J. & Bellanger, D. Exenatide, dapagliflozin, or phentermine\/topiramate differentially affect metabolic profiles in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 106, 3019\u20133033 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1646_CR139","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4093\/dmj.2014.38.4.302","volume":"38","author":"DK Song","year":"2014","unstructured":"Song, D. K., Lee, H., Oh, J.-Y., Hong, Y. S. & Sung, Y.-A. FTO gene variants are associated with PCOS susceptibility and hyperandrogenemia in young Korean women. Diabetes Metab. J. 38, 302\u2013310 (2014).","journal-title":"Diabetes Metab. J."},{"key":"1646_CR140","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.fertnstert.2016.10.039","volume":"107","author":"H Zhao","year":"2017","unstructured":"Zhao, H. et al. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter. Fertil. Steril. 107, 467\u2013474 (2017).","journal-title":"Fertil. Steril."},{"key":"1646_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-024-01056-7","volume":"23","author":"M Sharifi","year":"2024","unstructured":"Sharifi, M., Saber, A., Moludi, J., Salimi, Y. & Jahan-Mihan, A. The effects of portfolio moderate-carbohydrate and ketogenic diets on anthropometric indices, metabolic status, and hormonal levels in overweight or obese women with polycystic ovary syndrome: a randomized controlled trial. Nutr. J. 23, 152 (2024).","journal-title":"Nutr. J."},{"key":"1646_CR142","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/humrep\/deac047","volume":"37","author":"RK Patten","year":"2022","unstructured":"Patten, R. K. et al. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial. Hum. Reprod. 37, 1018\u20131029 (2022).","journal-title":"Hum. Reprod."},{"key":"1646_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168713","volume":"25","author":"J Niepsuj","year":"2024","unstructured":"Niepsuj, J., Piwowar, A., Franik, G. & Bizo\u0144, A. Impact of smoking and obesity on the selected peptide hormones and metabolic parameters in the blood of women with polycystic ovary syndrome\u2014preliminary study. Int. J. Mol. Sci. 25, 8713 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1646_CR144","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fendo.2020.00274","volume":"11","author":"Y Tian","year":"2020","unstructured":"Tian, Y. et al. PCOS-GWAS susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS. Front. Endocrinol. 11, 274 (2020).","journal-title":"Front. Endocrinol."},{"key":"1646_CR145","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09924-5","volume":"51","author":"RA Rasheed","year":"2024","unstructured":"Rasheed, R. A., Rasheed, P. H. & Ali, A. M. Metabolic and hormonal profiling in polycystic ovarian syndrome: insights into INSR gene variations. Mol. Biol. Rep. 51, 989 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"1646_CR146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/THC-218002","volume":"29","author":"X Zhong","year":"2021","unstructured":"Zhong, X. et al. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of polycystic ovary syndrome (PCOS). Technol. Health Care 29, 11\u201325 (2021).","journal-title":"Technol. Health Care"},{"key":"1646_CR147","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-animal-111523-102259","volume":"13","author":"M Bellingham","year":"2025","unstructured":"Bellingham, M., Evans, N. P., Lea, R. G., Padmanabhan, V. & Sinclair, K. D. Reproductive and metabolic health following exposure to environmental chemicals: mechanistic insights from mammalian models. Annu. Rev. Anim. Biosci. 13, 411\u2013440 (2025).","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"1646_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2025.110232","volume":"150","author":"J Su","year":"2026","unstructured":"Su, J. et al. The role of folic acid and vitamin B12 in gestational diabetes mellitus and offspring development: a narrative review. J. Nutr. Biochem. 150, 110232 (2026).","journal-title":"J. Nutr. Biochem."},{"key":"1646_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01375-2","volume":"23","author":"W Ma","year":"2025","unstructured":"Ma, W. et al. Association of LHCGR rs2293275 genotype with ovarian aging in Chinese women: a multicenter population-based study. Reprod. Biol. Endocrinol. 23, 41 (2025).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1646_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01251-9","volume":"22","author":"S Singh","year":"2022","unstructured":"Singh, S., Kaur, M., Kaur, R., Beri, A. & Kaur, A. Association analysis of LHCGR variants and polycystic ovary syndrome in Punjab: a case\u2013control approach. BMC Endocr. Disord. 22, 335 (2022).","journal-title":"BMC Endocr. Disord."},{"key":"1646_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2025.109415","volume":"198","author":"M S\u00e4ve-S\u00f6derbergh","year":"2025","unstructured":"S\u00e4ve-S\u00f6derbergh, M. et al. Per- and polyfluoroalkyl substances (PFAS) in drinking water, gestational diabetes mellitus, hypertension and preeclampsia: a nation-wide register-based study on PFAS in drinking water. Environ. Int. 198, 109415 (2025).","journal-title":"Environ. Int."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01646-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:49:22Z","timestamp":1792086562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01646-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":151,"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01646-1","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}